Dexiang Biotech | Intelligent Microfluidic Technology

Breakthroughs in Blood Testing Technology

Tianjin Dexiang Biotechnology Co., Ltd. (hereinafter referred to as Dexbio), established in 2011, is a leading biotechnology firm engaged in specializing in research, development, production, and sales in the field of in vitro diagnostics. Dexbio specializes in microfluidic technology, pre-transfusion testing technology, and smart pipeline technology, and has over 60 patented technologies and a rich product portfolio. It has significant advancements in column agglutination technology, platelet antibody detection technology, microfluidic technology, and antigen purification technology. Dexbio has established a Sci-Tech Innovation Acceleration Center for medical devices and in vitro diagnostics, along with an Idea Validation Platform and a Postdoctoral Research Workstation Substation. Dexbio’s marketing network and technical support team cover 30 provinces, municipalities, and autonomous regions across the country.

Dexbio has earned accolades including one of the first batch of key National-level “Little Giants” in the new round of national initiatives, National High-tech Enterprise, National-level Specialized and Innovative “Little Giant” Enterprise, China Hidden Unicorn Enterprise, Tianjin Gazelle Enterprise, Leading Enterprise in the Strategic Emerging Industries in Tianjin, and Tianjin Technology Leading Enterprise.

Microfluidic Series Test Cards

Dexbio’s self-developed microfluidic series testing cards apply microfluidic technology to the field of safe blood transfusion, holding complete independent intellectual property rights. The core patents cover both the reagents and the instruments, with invention patents granted in China, the United States, and the European Union. Dexbio has successfully developed the industry’s first intelligent blood typing analyzer and the first intelligent blood typing analysis production line. The commercialization project of the microfluidic smart blood transfusion testing platform won the 2021 National Innovation Award from the China Invention Association and the 2024 Major Scientific and Technological Special Project in Tianjin.